tection is predictive of mortality among patients bacteremic with non-E. coli Enterobacteriaceae but not E. coli is surprising given the presumed commonality of the hexa-acyl lipid A structure among Enterobacteriaceae species.
Introduction
There is extensive evidence implicating endotoxin in the pathogenesis of Gram-negative (GN) sepsis [1, 2] . Hence, an assay to detect endotoxemia would appear to be a logical adjunct toward targeting novel therapies for sepsis including those specifically directed against endotoxin [3] .
However, among large clinical studies, the predictive value of endotoxemia detection remains unclear [4] and a disconnect with animal models exists [5, 6] . On the one hand, studies of patients with plague [7, 8] , or meningococcemia [9] , have found a quantitative correlation between the level of endotoxemia and the degree of organ dysfunction or mortality. On the other hand, larger studies of sepsis in which the type of GN bacteremias were not restricted to any specific GN species type [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , have generated findings that were contradictory. In aggregate, the results from these studies indicate that endotoxemia detection is a borderline predictor of mortality risk (odds ratio <2) [4, 21] .
These and some experimental observations [22, 23] raise doubt as to whether the relationship between endotoxemia and outcome is equal for GN bacteremias of different species type. Clarification might also help to reconcile conflicting observations in the clinical literature especially given the variable prevalence of different GN bacteremia species types in different studies [4] .
The objective here is to re-examine the prognostic value of endotoxemia in association with bacteremias with Escherichia coli versus other species of GN bacteria in the light of four observations. Firstly, mortality occurs less frequently for E. coli bacteremias versus other types of GN bacteremias [24] [25] [26] . Second, there are specific structural differences in lipid A, the biologically active component of endotoxin (lipopolysaccharide, LPS) for Enterobacteriaceae including E. coli versus other GN bacteria such as non-Enterobacteriaceae [1] . There are important discrepancies between the in vivo biological activities of the endotoxins of different types of GN bacteria versus their activities in the limulus assay, which is the most commonly used assay for endotoxemia detection [22, 27, 28] . Finally, endotoxemia is undetectable for >20% of GN bacteremias overall and >40% of E. coli [29] bacteremias.
Methods

Data Sources
A computerized search of PubMed (including Medline) was undertaken using the key words 'endotoxemia' and 'limulus' in the title or abstract and was restricted to studies in humans. This search was supplemented by a hand search for studies reporting mortality outcome data in relation to endotoxemia detection and detection of GN bacteremia with blood culture for patient groups at risk of GN bacteremia. This search has been performed and repeatedly updated [21, 29] between 1993 and April 2012 as detailed previously [4] and a call for data was issued [30] . Additional data was obtained through correspondence with authors of potentially eligible studies.
Study Selection
The study inclusion criteria was as detailed previously [4] with the following additional criteria: (1) at least 5 patients with GN bacteremia, and (2) survival outcome available on an individual patient basis in relation to endotoxemia detection and type of GN bacteremia. Additional information was received by personal communication for 11 studies.
The studies were classified as to whether they were not restricted to examining specific GN bacteremias (unrestricted studies), versus studies that were so restricted (restricted studies) to a single GN pathogen type (e.g., Salmonella typhi , Neisseria meningitidis , Yersinia pestis , and Burkholderia pseudomallei ). For the unrestricted studies, the individual patients with mono-microbial GN bacteremias were classified into four groups as follows: (1) GN bacteremias with E. coli, (2) GN bacteremias with Enterobacteriaceae other than E. coli (e.g., Klebsiella pneumoniae, Enterobacter species, Serratia marcescens, Proteus mirabilis, and Providencia rettgeri ), (3) GN bacteremias other than Enterobacteriaceae (e.g., Pseudomonas species, Acinetobacter species, and Bacteroides species). According to the classification by Munford [1] , the GN bacteria of the first two groups are known to have a hexa-acyl lipid A whereas those of the third group usually have a lipid A that is either non-hexa-acyl or of unknown structure. The following GN bacteremias were not included in this analysis due to small numbers and uncertainties in classification: Campylobacter species, Neisseria gonnorhoeae , non-typhi Salmonellae, Haemophilus influenzae.
Data Extraction and Analysis: Calculation of an Odds Ratio
The endotoxemia detection and mortality outcome data for all studies was extracted for those with GN bacteremia on a per patient basis. The determination of endotoxemia present versus absent was as recorded in the original publication without any attempt to standardize endotoxemia detection levels across publications. An odds ratio (OR) was then calculated as follows: OR = (endotoxemia positive with fatal outcome/endotoxemia positive with non-fatal outcome)/(endotoxemia negative with fatal outcome/endotoxemia negative with non-fatal outcome).
For the purposes of graphical representation, a forest plot was generated using summary OR and 95% confidence intervals (CI) as derived using The Mantel-Haenszel method in which 0.5 was added to any cell containing a zero to avoid deriving ORs that were undefined. These calculations and graphics were undertaken using the 'Metan' command [31] in STATA (release 11.0; STATA Corp., College Station, Tex., USA). This enables both a visual and statistical evaluation of homogeneity [32] .
There exists within the dataset the following data issues: small samples, sparse data and zero cells. Hence, two different methods of statistical analysis were undertaken. First, to allow for these issues summary level ORs and 95% CIs for each category of GN bacteremia were derived by exact grouped logistic regression (ELR) methods using the 'exlogistic' command in STATA.
Second, because the mortality proportions had been derived from clusters of patients within studies, the independence of the data is not a tenable assumption. This assumption is vitiated by the potentially infectious nature of some of the GN bacteremias under study. Hence, for the purpose of comparisons across categories of GN bacteremias and to derive a test for interaction between the detection of endotoxemia and the type of GN bacteremia, the method of generalized estimating equations (GEE) was used [33] .
Results
There were 17 studies that were not restricted ( table 1 ) and 10 studies that were restricted ( table 2 ) to a single GN pathogen type.
Unrestricted Studies
Eight unrestricted studies [12, [14] [15] [16] [17] [34] [35] [36] undertaken in an ICU setting were identified reporting the results for a total of 233 GN bacteremic patients of which 76 (33%) had a fatal outcome ( table 1 ). In these studies E. coli was the most common GN bacteremia and had the least mortality (107 with 27 deaths; 25%), versus non-E. coli Enterobacteriaceae (75 with 26 deaths; 35%) and versus non-Enterobacteriaceae (51 with 23 deaths; 45%). There were an additional 9 non-ICU studies in which there were 86 GN bacteremias in the three categories with 21 fatalities (24%). Among these 9 unrestricted non-ICU studies are 4 studies limited to adult patients [37] [38] [39] [40] , 3 studies of febrile oncology patients [41] [42] [43] and 2 studies limited to a pediatric age group [44, 45] ( table 1 ) . In only 3 studies [38] [39] [40] was it explicitly stated that endotoxemia [12, 14, 36, 39, 40, 42, 44, 45] , median [16, 17, 34, 35] , or peak [15, 37, 38] level of multiple levels or was the level taken on a single [41, 43] occasion. c Refers to survival census day. d Non-E. coli Enterobacteriaceae includes the following bacteremias: Klebsiella species, Enterobacter species, Proteus species, and Serratia species. e Non-Enterobacteriaceae includes the following bacteremias: Pseudomonas species, Acinetobacter species, and Bacteroides species. f Data for these studies [12, 14 -17, 39, 40, 42, 43] provided by personal communication. g Goldie et al. [16] -H. influenzae bacteremia (n = 1) from this study not included. h Guidet et al. [17] -H. influenzae bacteremia (n = 1) from this study not included. i Maury et al. [35] -H. influenzae bacteremia (n = 1) from this study not included. j Opal et al. [12] -data for this study stratified into two categories of endotoxemia detected: low (20 -660 pg/ml) and high (>660 pg/ml) versus endotoxemia not detected (<20 pg/ml). k Data for these studies were collapsed into a single category to enable their representation within figure 1. determinations were obtained prior to the administration of antibiotic therapy whereas for the remaining studies this was not stated.
The summary ORs for the three categories of GN bacteremias are summarized in table 3 and presented as a forest plot in figure 1 . The largest study [12] provided data in relation to endotoxemia detection at two breakpoints which have been used here to stratify the mortality proportions from this study within figure 1 . None of the study level ORs ( fig. 1 ) were significantly elevated above 1 for any of the three categories of GN bacteremia ( table 3 ). The I 2 associated with each of these summary ORs was <10%, indicating minimal heterogeneity ( fig. 1 ) .
For an analysis with all the unrestricted studies included, only in the case of non-E. coli Enterobacteriaceae was the summary OR significantly elevated above 1, indicative of a worse outcome in endotoxemic patients ( table 3 ) . The I 2 associated with each of these summary ORs was again <10% (data not shown). The increased mortality for this category is particularly apparent for Klebsiella species (9 of 13 deaths in 8 studies if endotoxemia was detected vs. 2 of 17 deaths in 6 studies if endotoxemia was not detected). The method used to derive the summary ORs in either figure 1 or table 3 made no substantive difference to the overall findings. For an analysis with only the ICU studies included, none of the summary ORs were significantly elevated above 1.
Enterobacteriaceae Bacteremias and Endotoxemia
The effect of the detection of endotoxemia on mortality for GN bacteremias with E. coli versus Enterobacteriaceae other than E. coli ( table 3 ) was tested as an interaction term within a regression model. This interaction term was found to be significant indicating an impact of endotoxemia detection on prognosis additional to the impact of GN bacteremia type. This interaction term was found to be significant (OR 2.8; 1.01-8.1) for all unrestricted studies ( table 3 ) and also for an analysis limited to the studies undertaken in ICU setting (OR 3.8; 1.13-12.8).
Restricted Studies
There were 10 studies that were restricted to one of the following four GN pathogen types ( table 2 ): Neisseria meningitidis (4 studies [9, [46] [47] [48] ), Burkholderia pseudomallei (1 study [52] ), Yersinia pestis (2 studies [7, 8] ), and Salmonella typhi (3 studies [49] [50] [51] ) in which 201 bacteremic patients experienced 50 (25%) fatal outcomes. For these GN bacteremias, only in the case of Neisseria men- ingitidis bacteremia was the summary OR for mortality significantly elevated (26.0; 1.6-321; p < 0.0001) in association with the detection of endotoxemia ( table 3 ) .
Discussion
GN bacteremia has a high mortality and observations derived from animal models implicate a key role for endotoxemia in its pathogenesis. From this, it could be hypothesized that the differences in relative frequency of detection of concomitant endotoxemia with GN bacteremia on the one hand [30, 53, 54] , or the known differences in the structure activity relationship of the lipid A component of the endotoxin molecule on the other [1, 22, 27-28] , might account for differences in mortality between bacteremias with Enterobacteriaceae versus other GN bacteria. However, the findings here were unexpectedly otherwise.
This analysis updates two previous meta-analyses [21, 53] applying current analytic methodology [31, 33] , using available patient level data to enable questions relating to the interaction between GN bacteremia species type and endotoxemia detection on prognosis to be addressed.
There are several obstacles to resolve in undertaking the analysis presented here. Firstly, the studies were diverse with respect to their dates of publications, sizes, study designs, endotoxemia breakpoint levels, survival census times, patient populations, and settings. By contrast, the studies conducted in the ICU setting exhibited less diversity with respect to these features and were all large and published in the 1990s. Second, the data is sparse, unbalanced and clustered. In undertaking a meta-analysis the Mantel-Haenszel method is commonly used for data analysis and also to provide a graphical summary together with computational tests for heterogeneity. However, this method may be suboptimal for deriving and comparing summaries under the data conditions found here. So two additional analytic methods were employed here. Logistic regression using exact methods and the method of generalized estimating equations are more computationally intensive methods which allow a population-averaged summation under less restrictive assumptions regarding the underlying population distributions and data independence [33] .
There are five findings here: (1) The prognostic value of endotoxemia detection in association with GN bacteremia studies varies across dif- ferent GN bacteremia species. This variability across species types, which is in contrast to the lack of heterogeneity across studies, is visually apparent in the forest plot ( fig. 1 ) . (2) The endotoxemia detection in association with bacteremias with Neisseria meningitidis and with Enterobacteriaceae other than E. coli has a strong prognostic value. (3) Surprisingly, the detection of endotoxemia in association with E. coli bacteremia, which is the second largest GN bacteremia category here, has no prognostic value. No single study included here would have been large enough to demonstrate this observation. As a sensitivity analysis, it was found that it would require at least three studies each having at least 40 patients with E. coli bacteremias with an OR for mortality of >10 in association with the detection versus non-detection of endotoxemia to change the conclusions found here (data not shown). It is unlikely that such studies would be unpublished or easily overlooked. (4) The overall better prognosis associated with E. coli bacteremias [25] versus non-E. coli Enterobacteriaceae ( table 3 ) cannot be attributed to endotoxemia being less frequently detectable among E. coli bacteremias. Forest plot of mortality OR of patients with GN bacteremia in relation to whether endotoxemia was (etx+) or was not (etx-) detected presented as study specific and summary OR and 95% CI. 'etx-less survival' and 'etx+ less survival' indicates the respective OR ranges for which mortality was more common in association with either endotoxemia non-detection or detection, respectively. Arrowheads indicate 95% CIs that extend out of range.
(5) For the largest study [12] , the 135 GN bacteremic patients were able to be classified into subgroups with high (>660 pg/ml), low (25-660 pg/ml) and non-detectable (<25 pg/ml) levels of endotoxemia. This simple dose-response analysis did not suggest a higher mortality OR with higher levels of endotoxemia in any of the three GN bacteremia categories studied ( fig. 1 ). These findings are particularly surprising given that the lipid A structure of LPS (endotoxin) of Enterobacteriaceae, including E. coli , is typically hexa-acyl, a structure which is known to have a key role toward recognition by the MD2:TLR4 receptor and the stimulation of cytokine release [1, 55] .
Limitations
There were small numbers of bacteremias with Yersinia pestis (plague), and Salmonella typhi (typhoid) and the non-Enterobacteriaceae, and within these bacteremia groups there were small numbers with endotoxemia not detected. Hence the estimates of mortality proportions for these categories of GN bacteremias and the impact of endotoxemia detection are least stable to the appearance of additional data.
Many relevant patient-specific details such as age and patient comorbidities were not available. Both endotoxemia and GN bacteremia are episodic phenomena [56] and endotoxemia levels may be increased by antibiotic therapy [57] . For all but three studies the timing of antibiotic administration in relation to these determinations is unclear. Moreover, the breakpoints used to determine a positive endotoxemia result differed across the studies.
The studies examined in this analysis differed from each other in several respects and several study level factors would have potentially varied over the time period over which these studies had been conducted. For example, the antibiotic and supportive therapies, and the blood culture methods for detecting GN bacteremias, have not been considered here. These are all factors that could be expected to have varied over the more than 25 years covered in this overview, particularly with respect to the studies published prior to 1990.
Despite the diverse mix of study designs and settings, all summary ORs are associated with I 2 less than 10%, a finding that indicates minimal heterogeneity. This is a surprising finding given the diversity of patient groups, underlying risk, and clinical settings. Minimal heterogeneity was also noted with the analysis repeated with studies undertaken in non-ICU settings included. The studies undertaken in the ICU setting were of particular interest as published benchmarks for the mortality proportions for GN bacteremias in this patient group are available [25] . For example, the median mortality proportion among >1,000 bacteremias in ICU patients abstracted from >7 large studies is 19%, 28-30% and 32% for bacteremias with E. coli , Enterobacteriaceae other than E. coli , and P. aeruginosa , respectively [25] which can be used as literature-derived benchmarks. Among the three GN bacteremia categories noted in the studies included here ( table 3 ) , the mortality proportions and their relative rankings are similar to these benchmarks [25] .
This overview is based on a summation of observational studies. While the mortality risk in association with the detection of endotoxemia is increased for some but not all types of GN bacteremias, this overview is unable to identify the causal mechanism for this increased risk.
An increased OR for mortality in association with the detection of endotoxemia may be due to other associations. For example, the highly significant OR for mortality in association with meningococcemia may be confounded by the quantitative level of bacteremia. Brandtzaeg and colleagues [58] have found that the level of endotoxemia correlates with the level of neisserial DNA in plasma in this patient group. Likewise for other GN bacteremias, the level of bacteremia, as reflected using quantitative blood culture methods [59] or in time to blood culture positivity [60, 61] , is an important determinant of prognosis.
However, the kinetics of bacteremia, endotoxemia and pathophysiology may not be concordant. For example, in one clinical study [15] of 100 patients with sepsis in an ICU setting, the cumulative percent found to have endotoxemia rose from 20 to 40% between 0 and 24 h after study entry. Moreover, there are observations in animal models of septic shock conducted under controlled conditions with quantitative measurements of endotoxemia, GN bacteremia, hemodynamic changes and duration of survival which relate to this non-concordance [22, 23] . Following intraperitoneal challenge with strains of E. coli which have (O6:H1:K2) or do not have (O86:H8) virulence factors for human disease, survival time was shorter and the associated hemodynamic changes were more severe after challenge with the virulent strain, as might be expected. However, there are three paradoxical observations as follows: (1) bacteremia occurred earlier and more frequently after challenge with the avirulent E. coli strain; (2) levels of endotoxemia were three-fold higher after challenge with the avirulent E. coli strain, and (3) challenge with heat-killed bacteria at a ten-fold higher dose was associated with a reversal of the effects on survival and hemodynamic change seen with live bacterial challenge: the survival was now significantly shortened after challenge with the killed non-virulent bacteria versus the killed virulent bacteria. Despite this reversal, the levels of endotoxemia were again three-fold higher after challenge with the killed avirulent versus the killed virulent E. coli strain [22, 23] .
The co-presence of endotoxemia and GN bacteremia may also reflect important differences in host factors. In a study of 68 patients with GN bacteremia, Young [62] found a strong association between endotoxemia and recognized adverse prognostic host factors such as leukopenia, low opsonic titers in plasma against the autologous bacteremia strain and more severe underlying disease. Also, in an animal model, it has been noted that endotoxemia impedes the clearance of bacteremia [63] .
It is notable that endotoxin derived from E. coli is used commonly in animal and preclinical studies [64] . Moreover, future clinical investigations should consider the types and co-detection of GN bacteremia as confounding factors [65] in clinical associations of endotoxemia.
Conclusion
The impact of co-detection of endotoxemia with GN bacteremia on patient prognosis is unequal for different types of GN bacteremia, even amongst Enterobacteriaceae. This finding is surprising given the commonality of hexa-acyl lipid A structures among the endotoxins of Enterobacteriaceae. In the light of experimental findings, it is plausible that the unexpected clinical observations here may reflect differential kinetics of endotoxemia and GN bacteremia which are consequent on the presence of different virulence factors present in different species of GN bacteria [66] . boulis, Attikon University Hospital, Greece, and Dr. J. Prins, Academic Medical Center, The Netherlands, for the individual patient data. The manuscript has been submitted in partial fulfilment for the degree of Doctor of Medical Science at The University of Melbourne.
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